church
Showing 1326 - 1349 of 1,349
Overweight Trial in Danville, Philadelphia (telemedicine)
Unknown status
- Overweight
- telemedicine
-
Danville, Pennsylvania
- +1 more
Oct 22, 2008
Lupus Erythematosus, Systemic, Lupus Nephritis Trial in Worldwide (abetimus sodium (LJP 394) and/or solution, abetimus sodium
Terminated
- Lupus Erythematosus, Systemic
- Lupus Nephritis
- abetimus sodium (LJP 394) and/or placebo solution
- +2 more
-
Birmingham, Alabama
- +200 more
Mar 30, 2009
Coronary Artery Disease Trial in United States (TAXUS Express 2™)
Completed
- Coronary Artery Disease
- TAXUS Express 2™
-
Gilbert, Arizona
- +49 more
Sep 24, 2008
Pain Assessment, Incidence & Nature in Heart Failure
Completed
- Heart Diseases
-
San Diego, California
- +13 more
Jun 8, 2008
Prophylaxis for Herpes Simplex Trial in Worldwide (Herpes simplex candidate vaccine- adjuvanted GSK 208141, Placebo)
Completed
- Prophylaxis for Herpes Simplex
- Herpes simplex candidate vaccine- adjuvanted GSK 208141
- Placebo
-
La Jolla, California
- +46 more
Jun 16, 2008
Pain Trial in Worldwide (Parecoxib Sodium/Valdecoxib, Placebo/Valdecoxib, Placebo/Placebo)
Completed
- Pain
- Parecoxib Sodium/Valdecoxib
- +2 more
-
Fairhope, Alabama
- +206 more
Oct 9, 2008
The Atrial High Rate Episodes in Pacemaker Patients
Completed
- Arrhythmia
- +4 more
-
Hot Springs, Arkansas
- +41 more
Feb 22, 2008
Anxiety Disorder Trial in United States (a benzodiazepine drug)
Completed
- Anxiety Disorder
- a benzodiazepine drug
-
Bradenton, Florida
- +12 more
Jan 7, 2008
Heart Failure Trial in United States (Cardiac resynchronization therapy)
Completed
- Heart Failure
- Cardiac resynchronization therapy
-
Anchorage, Alaska
- +33 more
Dec 20, 2007
Arrhythmia Trial in Canada, United States (GAP-486 (ZP-123), 0.9% Sodium Chloride, USP)
Terminated
- Arrhythmia
- GAP-486 (ZP-123)
- 0.9% Sodium Chloride, USP
-
Sacramento, California
- +32 more
Dec 6, 2007
Coronary Disease, Coronary Arteriosclerosis, Hyperlipidemia Trial in Worldwide (torcetrapib/atorvastatin, atorvastatin)
Completed
- Coronary Disease
- +2 more
-
Birmingham, Alabama
- +146 more
Dec 6, 2007
Sepsis Trial in Worldwide (Drotrecogin alfa (activated), Placebo)
Completed
- Sepsis
- Drotrecogin alfa (activated)
- Placebo
-
Birmingham, Alabama
- +50 more
Nov 15, 2007
Schizophrenia Trial in United States (Divalproex Sodium Extended-Release Tablets, Olanzapine, Risperidone)
Completed
- Schizophrenia
- Divalproex Sodium Extended-Release Tablets
- +2 more
-
Birmingham, Alabama
- +34 more
Aug 2, 2006
Bipolar Disorder Trial in United States (Divalproex Sodium (Depakote ER))
Completed
- Bipolar Disorder
- Divalproex Sodium (Depakote ER)
-
Cerritos, California
- +17 more
Aug 2, 2006
Hemorrhagic Shock Trial in United States (Poly SFH-P Injection)
Unknown status
- Hemorrhagic Shock
- Poly SFH-P Injection
-
San Diego, California
- +31 more
Jul 31, 2006
Sepsis Trial in Worldwide (sPLA2 Inhibitor)
Completed
- Sepsis
- sPLA2 Inhibitor
-
Birmingham, Alabama
- +86 more
Jul 18, 2006
Cardiovascular Disease Trial in Canada, United Kingdom, United States (Hemolink (hemoglobin raffimer IV solution))
Suspended
- Cardiovascular Disease
- Hemolink (hemoglobin raffimer IV solution)
-
San Francisco, California
- +27 more
Jun 23, 2005
Trial of Smoking Cessation Programs in Black Churches
Completed
- Cardiovascular Diseases
- +2 more
- (no location specified)
Jun 23, 2005
Stroke, Cerebral Infarction Trial in Chicago (aspirin, ticlopidine)
Completed
- Stroke
- Cerebral Infarction
-
Chicago, IllinoisRush-Presbyterian-St. Luke's Medical Center
Jun 23, 2005